跳至主要内容
临床试验/NCT04984850
NCT04984850已完成不适用

Feasibility, Acceptability, and Potential Effects of a Comprehensive Oral Chemotherapy Intervention on Medication Adherence Self-efficacy, Medication Adherence, and Symptom Distress: A Pilot Randomized Control Trial

McGill University2 个研究点 分布在 1 个国家目标入组 52 人开始时间: 2022年1月7日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
52
试验地点
2
主要终点
Feasibility and acceptability

研究概览

简要总结

Individuals on oral chemotherapy (OC) often face many challenges requiring adequate informational support, monitoring, and management. This pilot randomized control trial (RCT) aims to assess the feasibility, acceptability, and preliminary effects of a comprehensive OC intervention on medication adherence self-efficacy, medication adherence, and symptom distress.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Participant)

盲法说明

Following baseline, participants randomized immediately to receive either the intervention plus usual care (experimental group, n = 26) or usual care only (control group, n = 26).

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years of age or older
  • Diagnosis of cancer, any stage
  • Being followed by a care team at the affiliated hospital centre
  • About to start or within the first cycle of oral anticancer treatment (traditional cytotoxic, targeted therapy, hormonal therapy as active ongoing treatment for cancer with the aim of killing cancer cells/shrinking tumor size)
  • Has a computer/tablet/smartphone device with internet
  • The ability to communicate, read, and write in English or French

排除标准

  • Receiving IV chemotherapy, immunotherapy, and/or oral hormonal therapy as long-term maintenance treatment for prevention of cancer's return/growth of cancer cells after initial treatment
  • Significant physical or cognitive limitations that would prevent ability to participate in study as reported by patient, primary healthcare provider, or research staff
  • At imminent "end-of-life"
  • Participating in an ongoing clinical trial

研究组 & 干预措施

Intervention plus usual care

Experimental

干预措施: Oral chemotherapy information and support (Other)

Usual care only

No Intervention

结局指标

主要结局

Feasibility and acceptability

时间窗: Five months

Study feasibility assessed by the recruitment rate (percentage, dividing the total number of participants recruited throughout the study by the number of months recruitment occurred), retention rate (percentage, comparing the number of participants who complete baseline e-questionnaires to the number of participants who complete study exit e-questionnaires), response rate to study e-questionnaires (percentage, the number of completed follow-up e-questionnaire assessments for participants who complete the study), and uptake of intervention (percentage, calculated by comparing by number of participants who actually access the intervention to the total number who are given access). Intervention acceptability assessed by intervention burden, intervention coherence, and perceived effectiveness using the Tariman et al. (2011) Acceptability e-scale for web-based patient-reported outcomes in cancer care. Mean scores range from 1 to 5, higher score indicating higher acceptability.

次要结局

  • Potential effects of intervention via medication adherence self-efficacy, medication adherence and symptom distress(Five months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Carmen G. Loiselle, N., Ph.D.

Professor

McGill University

研究点 (2)

Loading locations...

相似试验